- $53.83m
- -$44.19m
- 27
- 99
- 45
- 58
Annual cashflow statement for Avrobio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -73 | -120 | -119 | -106 | 12.2 |
| Depreciation | |||||
| Non-Cash Items | 6.63 | 15.5 | 18.4 | 14.6 | -71.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.18 | 4.24 | 1.3 | -7.4 | -4.29 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -67.7 | -98.8 | -98 | -97.2 | -63.2 |
| Capital Expenditures | -1.58 | -1.18 | -2.46 | -0.267 | -0.008 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 85.1 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.58 | -1.18 | -2.46 | -0.267 | 85.1 |
| Financing Cash Flow Items | 0 | — | -0.308 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 130 | 173 | 30.4 | 0.262 | -16 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 60.7 | 72.6 | -70.1 | -97.2 | 5.86 |